A 4-site, single-visit intradermal postexposure prophylaxis regimen for previously vaccinated patients: Experiences with >5000 patients

Clinical Infectious Diseases

Volumn 51, Issue 9, 2010, Pages 1070-1072

  Shantavasinkul, Prapimporn ^a   Tantawichien, Terapong ^a,b   Jaijaroensup, Wipaporn ^a   Lertjarutorn, Samran ^a   Banjongkasaena, Ampai ^a   Wilde, Henry ^b   Sitprija, Visith ^a  

^a WHO Collaborating Center for Research on Rabies Pathogenesis and Prevention   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

DIPLOID CELL VACCINE; NEUTRALIZING ANTIBODY; PURIFIED CHICK EMBRYO CELL VACCINE; PURIFIED VERO CELL RABIES VACCINE; RABIES IMMUNOGLOBULIN; RABIES VACCINE; UNCLASSIFIED DRUG; VACCINE;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTIBODY TITER; ARTICLE; BITE; CHILD; DRUG DOSE REGIMEN; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; RABIES; RISK ASSESSMENT; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BITES AND STINGS; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION, SECONDARY; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; RABIES; RABIES VACCINES; RETROSPECTIVE STUDIES; THAILAND; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77958571294     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/656585     Document Type: Article

References (13)

1. Rabies vaccines. WHO position paper. Wkly Epidemiol Rec 2007; 82:425-435.
2. World Health Organization Expert Consultation on rabies. World Health Organ Tech Rep Ser 2005; 931:1-88, back cover.
3. Kositprapa C, Limsuwun K, Wilde H, et al. Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations. Clin Infect Dis 1997; 25:614-616. (Pubitemid 27392601)
4. Malerczyk C, Briggs DJ, Dreesen DW, Banzhoff A. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine. J Travel Med 2007; 14:63-64. (Pubitemid 46114989)
5. Suwansrinon K, Wilde H, Benjavongkulchai M, et al. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity. Vaccine 2006; 24:3878-3880.
6. Burridge MJ, Sumner JW, Baer GM. Intradermal immunization with human diploid cell rabies vaccine: serological and clinical responses of immunized persons to intradermal booster vaccination. Am J Public Health 1984; 74:503-505.
7. Rodrigues FM, Mandke VB, Roumiantzeff M, et al. Persistence of rabies antibody 5 years after pre-exposure prophylaxis with human diploid cell antirabies vaccine and antibody response to a single booster dose. Epidemiol Infect 1987; 99:91-95.
8. Vodopija R, Lafont M, Baklaic Z, Ljubicic M, Svjetlicic M, Vodopija I. Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine. Vaccine 1997; 15:571-574. (Pubitemid 27188625)
9. Tantawichien T, Benjavongkulchai M, Limsuwan K, et al. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine. Clin Infect Dis 1999; 28:1100-1103. (Pubitemid 29203546)
10. Tantawichien T, Supit C, Khawplod P, Sitprija V. Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis. Clin Infect Dis 2001; 33:2085-2087.
11. Khawplod P, Benjavongkulchai M, Limusanno S, et al. Four-site intradermal postexposure boosters in previously rabies vaccinated subjects. J Travel Med 2002; 9:153-155.
12. Wacharapluesadee S, Hemachudha T. Ante- and post-mortem diagnosis of rabies using nucleic acid-amplification tests. Expert Rev Mol Diagn 2010; 10:207-218.
13. Naraporn N, Khawplod P, Limsuwan K, et al. Immune response to rabies booster vaccination in subjects who had postexposure treatment more than 5 years previously. J Travel Med 1999; 6:134-136.